Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Oligodendroglioma 2Melanoma 2Leukemia, Myeloid, Acute 2Gliosarcoma 2Glioblastoma 2Central Nervous System Neoplasms 2Brain Neoplasms 2Astrocytoma 2Sarcoma, Kaposi 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Hodgkin Disease 1Histiocytosis 1Hemoglobinuria, Paroxysmal 1Hemoglobinuria 1Hematologic Neoplasms 1HIV Infections 1Glioma, Subependymal 1Glioma 1Anemia, Refractory, with Excess of Blasts 1Acquired Immunodeficiency Syndrome 1

Interventions

Temozolomide 4Radiotherapy 4Magnetic Resonance Spectroscopy 3Imatinib Mesylate 3Tamoxifen 2Donepezil 2Cisplatin 2Carboplatin 2Biopsy 2temsirolimus 1sargramostim 1fluorodopa F 18 1entinostat 1carboxyamido-triazole 1aldesleukin 1Vinblastine 1Topotecan 1Thalidomide 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiation 1Photochemotherapy 1Pharmacogenomic Testing 1Paclitaxel 1Muromonab-CD3 1Modafinil 1Mental Status and Dementia Tests 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Glioma, Subependymal × Muromonab-CD3 × Clear all
NCT00004024 2013-04-05

Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma

Barbara Ann Karmanos Cancer Institute

Phase 2 Completed
60 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡